首页> 外国专利> Processes for treating cancer selected from the group consisting of adencarcinoma and leukemia, and for eliciting T lymphocytes to infiltrating a tumor of a human.For eliciting an inflammatory immune response to a tumor of a human, for eliciting a response type hypersensitivity retarded tumor of a human, and,Composition for the treatment of cancer.

Processes for treating cancer selected from the group consisting of adencarcinoma and leukemia, and for eliciting T lymphocytes to infiltrating a tumor of a human.For eliciting an inflammatory immune response to a tumor of a human, for eliciting a response type hypersensitivity retarded tumor of a human, and,Composition for the treatment of cancer.

机译:选自腺癌和白血病的癌症的治疗方法,以及诱发T淋巴细胞浸润人的肿瘤的方法。对人的肿瘤引起炎症性免疫应答,对人的响应型超敏反应迟发性肿瘤的诱发方法。人和用于治疗癌症的组合物。

摘要

"Processes to treat cancer selected from the group consisting of adenocarcinoma and leukemia, and for eliciting T lymphocytes to infiltrate a tumor of a human.For eliciting an inflammatory response to a tumor of a human, for eliciting a response type hypersensitivity retarded tumor of a human, and composition for treatment of cancer.The present invention is directed to compositions and processes for the treatment of cancer.The compositions of this invention comprise a composition prepared from a tumor cell which is modified by hapteno and singeneica for the type of tumor to be treated.The composition has the properties when administered with an adjuvant to a human suffering from a malignant tumor of the same type as this cell of tumor.To elicit T lymphocytes that infiltrate the tumor of the human, eliciting an immune response against the tumor of the human inflammatory.And elicit a response delayed type hypersensitivity to the tumor of the human.The processes of the present invention is directed to cancer treatment comprising administration of a therapeutically effective amount of a composition comprising a cell of tumor.
机译:选自腺癌和白血病的癌症的治疗方法,以及引起T淋巴细胞浸润人的肿瘤的方法。对人的肿瘤引起炎症反应,引起的反应型超敏反应性迟发性肿瘤本发明涉及用于治疗癌症的组合物和方法。本发明的组合物包含由经hapteno和singeneica修饰的肿瘤细胞针对肿瘤类型制备的组合物。该组合物与佐剂一起给予患有与该肿瘤细胞相同类型的恶性肿瘤的人时具有的性质。引发渗入该人肿瘤的T淋巴细胞,引发针对该肿瘤的免疫应答。人类炎症性肿瘤并引发对人类肿瘤的迟发型超敏反应。本发明涉及癌症治疗,其包括给予治疗有效量的包含肿瘤细胞的组合物。

著录项

  • 公开/公告号BR9815983A

    专利类型

  • 公开/公告日2002-01-02

    原文格式PDF

  • 申请/专利权人 THOMAS JEFFERSON UNIVERSITY;

    申请/专利号BR19989815983

  • 发明设计人 DAVID BERD;

    申请日1998-08-10

  • 分类号A61K35/12;A61K35/26;A61K35/28;C12N5/08;C12N15/01;

  • 国家 BR

  • 入库时间 2022-08-22 00:46:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号